Please refer standalone and consolidated unaudited result for the quarter ended 31st December 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tejnaksh Healthcare reported a weak set of numbers for Q3 FY26. Consolidated revenue from operations fell to ₹261.62 lakh from ₹318.98 lakh in the year-ago quarter, a drop of about 18%. Consolidated profit after tax nearly halved to ₹28.82 lakh from ₹55.54 lakh, while profit before tax plunged to ₹35.65 lakh from ₹96.60 lakh. On a standalone basis, revenue declined to ₹169.08 lakh from ₹223.82 lakh and PAT dropped sharply to ₹22.78 lakh from ₹71.94 lakh YoY. Sequentially too, both revenue and profits slipped compared to the September 2025 quarter. The consolidated nine-month picture also shows revenue and profits well below the previous year. The auditor (Maheshwari & Co.) issued an unmodified limited review report on both the standalone and consolidated results.
Shareholders face a clear deterioration in operating performance with double-digit revenue decline and sharper profit compression, indicating margin pressure. Continued weakness in earnings could weigh on the stock in the near term despite the clean audit report.